The rapid evolution of modern medicine has spurred incredible advancements in vaccine and drug delivery. As the pace of innovation and drug discovery continues to accelerate, medical device R&D organizations have had to keep pace to effectively produce mechanisms to deliver these critical and emerging treatments. In this DeviceConnect, we’ll hear directly from leaders who are innovating on the medical and delivery sides to meet modern needs and patient scenarios.
– Saniya Ali, PhD, Chief Technology Officer and Co-founder, Watershed Therapeutics
– Deborah H. Fuller, PhD, Professor, Department of Microbiology, University of Washington School of Medicine
– Manjari Lal, PhD, Program Advisor, PATH
– Scott Thielman, Chief Technology Officer, Product Creation Studio